Wearable optical device distinguishes blood flow signals from the brain and scalp

An array of detectors points to new methods of monitoring blood flow after traumatic brain injuries and stroke.

2025-10-21

(Press-News.org) WASHINGTON, Oct. 21, 2025 — Measuring how well blood flows to the brain is crucial for understanding a wide range of neurological issues, from strokes to migraines to traumatic brain injuries. Obtaining such measurements noninvasively, however, remains a challenge. The scalp and skull not only obstruct viewing the brain directly but also have their own blood supply, further complicating cerebral blood flow measurements.

In APL Bioengineering, by AIP Publishing, researchers from the California Institute of Technology, the University of Southern California, Rancho Research Institute, the University of Toledo, and the National Neuroscience Institute of Singapore developed a system that uses optical spectroscopy to measure blood flow noninvasively.

Using an optical imaging method, the device can target different depths to distinguish between blood flow to the scalp and blood flow to the brain. The team demonstrated its use by temporarily blocking blood flow to the scalp at the superficial temporal artery and isolating its blood dynamics.

The work marks the first time this type of imaging — speckle contrast optical spectroscopy, which relies on shining light into blood and analyzing the blurring of speckles from elements of the blood — has been configured to tune out noise from blood flow to the scalp.

“We’ve established a safe, simple, and repeatable experimental framework that other researchers can use to validate their own noninvasive optical systems,” said author Max Huang. “Instead of relying solely on simulations, groups can now use superficial temporal artery occlusion to get real-world data on their device’s scalp versus brain sensitivity.”

The device is housed in a headband running across the forehead and contains a light source and seven detectors arranged in increasing distance from the artery. Closer detectors pick up shallower optical data, like signals from the scalp, while ones with a greater distance receive a deeper and broader set of signals.

Identifying which signals are closer to the skin’s surface, the group’s device can delineate which parts of the deeper signals correspond to blood flow in the brain.

They also found that temporarily blocking the superficial temporal artery, a blood vessel that originates near the ear and provides blood flow to the front of the scalp, significantly diminished the signals from the shallower channels corresponding to the scalp but didn’t change the signals from deeper channels. They did this by gently pressing down on the patients’ superficial temporal artery for a few seconds and measuring signals.

“Some individuals have thicker scalp or skull layers, while others have thinner ones,” said author Simon Mahler. “This variability makes it difficult to design a single device that can be easily used across a large cohort of participants and means that results can vary between individuals.”

The group next looks to expand on the device, including further validation and adding a sensor that allows it to be placed directly onto the skin.

###

The article “Assessing human scalp and brain blood flow sensitivities via superficial temporal artery occlusion using speckle contrast optical spectroscopy” is authored by Yu Xi Huang, Simon Mahler, Maya Dickson, Aidin Abedi, Yu Tung Lo, Patrick D. Lyden, Jonathan Russin, Charles Liu, and Changhuei Yang. It will appear in APL Bioengineering on Oct. 21, 2025 (DOI: 10.1063/5.0263953). After that date, it can be accessed at https://doi.org/10.1063/5.0263953.

ABOUT THE JOURNAL

APL Bioengineering is an open access journal publishing significant discoveries specific to the understanding and advancement of physics and engineering of biological systems. See https://pubs.aip.org/aip/apb.

###

END

ELSE PRESS RELEASES FROM THIS DATE:

USC-Caltech study moves novel tool to measure brain blood flow closer to the clinic

2025-10-21

Measuring blood flow in the brain is critical for responding to a range of neurological problems, including stroke, traumatic brain injury (TBI) and vascular dementia. But existing techniques, including magnetic resonance imaging and computed tomography, are expensive and therefore not widely available. Researchers from the USC Neurorestoration Center and the California Institute of Technology (Caltech) have built a simple, noninvasive alternative. The device takes a technique currently used in animal studies known as speckle contrast optical ...

Changes in colorectal cancer screening modalities among insured individuals

2025-10-21

About The Study: Among privately insured individuals, the use of colonoscopy and fecal immunochemical tests decreased after the COVID-19 pandemic while stool DNA test use increased, with differences by sex, area-level socioeconomic status, and metropolitan area residence. Corresponding Author: To contact the corresponding author, Sunny Siddique, MD, PhD, email sunny.siddique@yale.edu. To access the embargoed study: Visit our For The Media website at this link https://media.jamanetwork.com/ (doi:10.1001/jamanetworkopen.2025.38578) Editor’s Note: Please see the article for additional information, including ...

Seaweed makes for eco-friendly tissue scaffolds and reduces animal testing

2025-10-21

WASHINGTON, Oct. 21, 2025 — Seaweed is found around the world. In fact, the name “seaweed” comprises a diverse range of species, from microscopic phytoplankton to the giant forests found in various bodies of water. Seaweed species aren’t just crucial parts of marine ecosystems, though; they also provide numerous health benefits for humans and have been dubbed a superfood by marketing companies, a term used to encompass healthy, nutrient-rich foods. In Biointerphases, an AVS journal published by AIP Publishing, researchers from Oregon State University found yet another ...

New study: AI chatbots systematically violate mental health ethics standards

2025-10-21

PROVIDENCE, R.I. [Brown University] — As more people turn to ChatGPT and other large language models (LLMs) for mental health advice, a new study details how these chatbots — even when prompted to use evidence-based psychotherapy techniques — systematically violate ethical standards of practice established by organizations like the American Psychological Association. The research, led by Brown University computer scientists working side-by-side with mental health practitioners, showed that chatbots are prone to a variety of ethical violations. Those include inappropriately navigating crisis situations, ...

Smoking both cannabis and tobacco may alter brain’s ‘bliss molecule,’ study finds

2025-10-21

People who use both cannabis and tobacco show distinct brain changes compared to those who use cannabis alone, according to a new study led by McGill University researchers at the Douglas Research Centre. The finding may help explain why people who use both cannabis and tobacco often report increased depression and anxiety, and why quitting cannabis is harder for them than for people only using cannabis “This is the first evidence in humans of a molecular mechanism that may underlie why people who use both cannabis and tobacco experience worse outcomes,” said lead author Rachel Rabin, Associate Professor in McGill’s Department of Psychiatry ...

The rise of longevity clinics: Promise, risk, and the future of aging

2025-10-21

“The major issue is that longevity clinics not yet embedded within mainstream medical practice.” BUFFALO, NY — October 21, 2025 — A new editorial was published in Aging-US on October 13, 2025, titled “Longevity clinics: between promise and peril.” In this editorial, Marco Demaria, Editor-in-Chief of Aging-US, from the European Research Institute for the Biology of Ageing (ERIBA), University Medical Center Groningen (UMCG), University ...

Decoding the T-cell burst: Signature genes that predict T-cell expansion in cancer immunotherapy

2025-10-21

The ability of immune cells—particularly CD8+ T cells—to launch a rapid burst of proliferation inside tumors is key to the success of modern day cancer immunotherapies. However, the factors and mechanisms that drive this burst in proliferation remain poorly understood, making it difficult to predict which patients will benefit from treatment. A deeper understanding of this T cell burst could also guide the development of new therapies that enhance T cell proliferation and improve treatment outcomes. To tackle this challenge, an international team of researchers led by Associate Professor Satoshi Ueha and Professor Kouji Matsushima from the Research ...

Biomarker can help predict preeclampsia risk in women with sickle cell disease

2025-10-21

(WASHINGTON — October 21, 2025) – In pregnant women with sickle cell disease, the risk of developing early-onset preeclampsia can be determined by measuring levels of a protein associated with placental function and development. These findings provide insight that may help clinicians to anticipate and mitigate adverse pregnancy outcomes and were published in the journal Blood Advances. “Patients with sickle cell disease are at high risk for developing preeclampsia, but the challenge is that these patients ...

AI models can now be customized with far less data and computing power

2025-10-21

Engineers at the University of California San Diego have created a new method to make large language models (LLMs) — such as the ones that power chatbots and protein sequencing tools — learn new tasks using significantly less data and computing power. LLMs are made up of billions of parameters that determine how they process information. Traditional fine-tuning methods adjust all of these parameters, which can be costly and prone to overfitting — when a model memorizes patterns instead of truly understanding them, causing it to perform poorly on new examples. The new method developed by UC San Diego engineers takes a smarter approach. ...

Twenty-five centers join Bronchiectasis and NTM Care Center Network

2025-10-21

Miami (October 21, 2025) – The Bronchiectasis and NTM Association has accepted eight Care Center and 17 Clinical Associate Center sites in 14 states into the Bronchiectasis and NTM Care Center Network (CCN). The CCN includes 58 centers across the United States. The CCN aims to facilitate access to specialized care and support for the hundreds of thousands of people with bronchiectasis and nontuberculous mycobacterial (NTM) lung disease. “The prevalence of bronchiectasis and NTM lung disease continues to increase. Patients deserve access to high-quality, specialized care and resources,” said Doreen Addrizzo-Harris, M.D., Chair of ...